Leidos Holdings, Inc.: Form 10-Q for the period ended Oct 2, 2020
Filed with the SEC on Nov 2, 2020 and accepted by EDGAR at Nov 2, 2020, 13:38 ET.
Management's discussion and analysis
As filed, 33,724 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion and analysis of Leidos Holdings, Inc.'s ("Leidos") financial condition, results of operations, and quantitative and qualitative discussion about business environment and trends should be read in conjunction with Leidos' condensed consolidated financial statements and related notes.
The following discussion contains forward-looking statements, including statements regarding our intent, belief or current expectations with respect to, among other things, trends affecting our financial condition or results of operations, backlog, our industry, the impact of our merger and acquisition activity, government budgets and spending, our business contingency plans and our ability to recover certain costs through the Coronavirus Aid, Relief and Economic Security Act ("CARES Act"). Such statements are not guarantees of future performance and involve risks and uncertainties, including uncertainties relating to the coronavirus outbreak ("COVID-19") and the actions taken by authorities and us to respond, and actual results may differ materially from those in the forward-looking statements as a result of various factors. Some of these factors include, but are not limited to, the risk factors set forth in our Annual Report on Form 10-K, as updated by the risk factor in this report under Part II, Item 1A. "Risk Factors" and as may be further updated in subsequent filings with the U.S. Securities and Exchange Commission. Due to such uncertainties and risks, you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. We do not undertake any obligation to update these factors or to publicly announce the results of any changes to our forward-looking statements due to future events or developments.
Unless indicated otherwise, references in this report to "we," "us" and "our" refer collectively to Leidos and its consolidated subsidiaries.
Overview
We are a FORTUNE 500® science, engineering and information technology company that provides services and solutions in the defense, intelligence, civil and health markets, both domestically and internationally. We bring domain-specific capability and cross-market innovations to customers in each of these markets by leveraging seven core capabilities: cyber; digital modernization; integrated systems; mission software systems; mission support; operations and logistics; and sensors, collection and phenomenology. Our customers include the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security, the Federal Aviation Administration, the Department of Veterans Affairs and many other U.S. government civilian agencies, state and local government agencies and foreign government agencies. We operate in three reportable segments: Defense Solutions, Civil and Health. Additionally, we separately present the unallocable costs associated with corporate functions as Corporate.
Effective the beginning of fiscal 2020, certain contracts were reassigned from the Civil reportable segment to the Defense Solutions reportable segment. Prior year segment results have been recast to reflect this change.
COVID-19
The COVID-19 outbreak is affecting major economic and financial markets, and effectively all industries and governments are facing challenges, which has resulted in a period of business disruption, the length and severity of which cannot be predicted. The outbreak has resulted in significant travel restrictions, government orders to “shelter-in-place”, quarantine restrictions and significant disruption of the financial markets. We have acted to protect the health and safety of our employees, comply with workplace health and safety regulations and work with our customers to minimize disruptions. The outbreak has impacted each of our groups, primarily in access to customer sites, travel restrictions, limitations of remote work and COVID-19 related costs.
Consistent with federal, state and local guidance, we perform work that is essential to support the critical infrastructure of the United States, the Defense Industrial Base and healthcare sector and we continue to operate in support of our customers. We have taken steps to support increased teleworking and safe workplace environments. We have some minor business operations that are not designated as critical infrastructure and therefore have been required to operate in minimal conditions.
For the three and nine months ended October 2, 2020, COVID-19 adversely impacted revenues by approximately $40 million and $200 million, respectively, and impacted operating income for the three and nine months ended October 2, 2020 by an immaterial amount and approximately $79 million, respectively, as compared to prior year results. The full extent of the impact of the COVID-19 outbreak on our operational and financial performance, including our ability to execute on programs in the expected timeframe, will depend on future developments, including the duration and spread of the outbreak and related actions taken by the U.S. government, state and local government officials and international governments to prevent disease spread, all of which are uncertain and cannot be predicted. While we have been able to make some recoveries, the ultimate timing and amount of recoveries remain uncertain as they will depend on a range of government actions, including each government agency and/or contracting officer's implementation of the authority granted in Section 3610 of the CARES Act, a $2 trillion coronavirus response bill providing widespread emergency relief, including the availability of funds. As a result of Congress passing a continuing resolution, the relief from the CARES Act has been extended until December 11, 2020.
We have experienced delays, and expect to continue experiencing delays, on certain contracts as a result of standby leave absences, which has caused a portion of our contracts to be less profitable. Within our Health segment we did not experience any negative COVID impacts for the three months ended October 2, 2020 and anticipate to see recoveries in the fourth quarter of our fiscal year. We are seeking reimbursement of some of the COVID-19 related costs under our U.S. government contracts through a combination of equitable adjustments to the contract prices and reimbursement of the costs under Section 3610, which allows, but does not require, federal agencies to reimburse contractors at the minimum applicable contract billing rate for costs arising from certain paid leave, including sick leave, a contractor provides to keep its employees or subcontractors in a ready state, including to protect the life and safety of government and contractor personnel. Reimbursement of any costs under Section 3610 increases sales, but is not expected to include a profit or fee and so would have the effect of reducing our margins in future periods. Standby cost increases, including costs for employees whose jobs cannot be performed remotely, may not be fully recoverable under our contracts, particularly fixed-price contracts, or adequately covered by insurance. We also have no assurance that Congress will appropriate funds to cover the reimbursement of defense contractors authorized by the CARES Act, which could reduce funds available for recovery of these costs or for other U.S. government defense priorities.
The CARES Act also enabled us to defer our federal and some state income tax payments from the second quarter of fiscal 2020 to the third quarter of fiscal 2020 and also to defer payment of the employer portion of social security taxes for the balance of fiscal 2020. For the three and nine months ended October 2, 2020, we deferred $92 million of employer social security tax payments and received $10 million from the Employee Retention Credit.
We have taken measures to protect the health and well-being of our workforce and are working with our customers to minimize the delay and disruption of the award and performance on our contracts. Many of our employees continue to work remotely while our offices remain open with limited capacity.
Business Environment and Trends
U.S. Government Markets
During the three and nine months ended October 2, 2020, we generated approximately 88% of our total revenues from contracts with the U.S. government. Accordingly, our business performance is affected by the overall level of U.S. government spending, especially on national security, homeland security and intelligence, and the alignment of our service and product offerings and capabilities with current and future budget priorities of the U.S. government.
On February 10, 2020, the President submitted the government fiscal year ("GFY") 2021 budget proposal to Congress, which included discretionary spending levels for defense and non-defense programs of $741 billion and $590 billion, respectively. Since then, Congress and the Administration have shifted their collective attention to mitigating the impact of COVID-19.
Congress is currently addressing the passage of appropriations bills for GFY 2021. Prior to the beginning of GFY 2021, Congress passed a continuing resolution that was enacted on October 1, 2020 to provide temporary funding for government operations at GFY 2020 enacted levels until December 11, 2020.
International Markets
Sales to customers in international markets represented approximately 8% of total revenues for the three and nine months ended October 2, 2020. Our international customers include foreign governments and their agencies. Our international business increases our exposure to international markets and the associated international regulatory and geopolitical risks.
Changes in international trade policies, including higher tariffs on imported goods and materials, may increase our procurement costs of certain IT hardware used both on our contracts and for internal use. However, we expect to recover certain portions of these higher tariffs through our cost-plus contracts. While we evaluate the impact of higher tariffs, currently, we do not expect tariffs to have a significant impact to our business.
Results of Operations
The following table summarizes our condensed consolidated results of operations for the periods presented:
(dollars in millions)
| Three Months Ended October 2, 2020 | September 27, 2019 | Dollar change | Percent change | Nine Months Ended October 2, 2020 | September 27, 2019 | Dollar change | Percent change | |
|---|---|---|---|---|---|---|---|---|
| Revenues | $3,242 | $2,835 | $407 | 14.4% | $9,045 | $8,140 | $905 | 11.1% |
| Operating income | 258 | 249 | 9 | 3.6% | 699 | 651 | 48 | 7.4% |
| Non-operating expense, net | (44) | (35) | (9) | 25.7% | (163) | (12) | (151) | NM |
| Income before income taxes | 214 | 214 | — | —% | 536 | 639 | (103) | (16.1)% |
| Income tax expense | (51) | (52) | 1 | (1.9)% | (104) | (150) | 46 | (30.7)% |
| Net income | 163 | 162 | 1 | 0.6% | 432 | 489 | (57) | (11.7)% |
| Net income attributable to Leidos common stockholders | $163 | $161 | $2 | 1.2% | $431 | $486 | $(55) | (11.3)% |
| Operating margin | 8.0% | 8.8% | 7.7% | 8.0% |
NM - Not meaningful
Segment and Corporate Results
(dollars in millions)
| Defense Solutions | Three Months Ended October 2, 2020 | September 27, 2019 | Dollar change | Percent change | Nine Months Ended October 2, 2020 | September 27, 2019 | Dollar change | Percent change |
|---|---|---|---|---|---|---|---|---|
| Revenues | $1,951 | $1,594 | $357 | 22.4% | $5,413 | $4,645 | $768 | 16.5% |
| Operating income | 145 | 107 | 38 | 35.5% | 359 | 324 | 35 | 10.8% |
| Operating margin | 7.4% | 6.7% | 6.6% | 7.0% |
The increase in revenues for the three months ended October 2, 2020, as compared to the three months ended September 27, 2019, was primarily attributable to $302 million of revenues related to the acquisition of Dynetics, Inc. ("Dynetics"), program wins and favorable exchange rate movements, primarily related to changes in the Australian dollar when compared to the U.S. dollar. This was partially offset by the completion of certain contracts and approximately $26 million of negative impacts from reduced volume on certain contracts due to COVID-19.
The increase in revenues for the nine months ended October 2, 2020, as compared to the nine months ended September 27, 2019, was primarily attributable to $637 million of revenues related to the acquisition of Dynetics, program wins and a net increase in volumes on certain programs. This was partially offset by the completion of certain contracts and approximately $59 million of negative impacts from reduced volume on certain contracts due to COVID-19.
The increase in operating income for the three months ended October 2, 2020, as compared to the three months ended September 27, 2019, was primarily due to program wins, lower indirect expenditures and income related to the acquisition of Dynetics. This was partially offset by a net decrease in volumes on certain programs.
The increase in operating income for the nine months ended October 2, 2020, as compared to the nine months ended September 27, 2019, was primarily due to program wins, lower indirect expenditures and income related to the acquisition of Dynetics. This was partially offset by a net decrease in volumes on certain programs, including approximately $24 million of negative impacts from reduced volume on certain contracts due to COVID-19, and higher amortization of intangible assets related to the acquisition of Dynetics.
(dollars in millions)
| Civil | Three Months Ended October 2, 2020 | September 27, 2019 | Dollar change | Percent change | Nine Months Ended October 2, 2020 | September 27, 2019 | Dollar change | Percent change |
|---|---|---|---|---|---|---|---|---|
| Revenues | $771 | $733 | $38 | 5.2% | $2,183 | $2,023 | $160 | 7.9% |
| Operating income | 54 | 43 | 11 | 25.6% | 191 | 157 | 34 | 21.7% |
| Operating margin | 7.0% | 5.9% | 8.7% | 7.8% |
The increase in revenues for the three months ended October 2, 2020, as compared to the three months ended September 27, 2019, was primarily attributable to $74 million of revenues related to the acquisition of L3Harris Technologies' security detection and automation businesses (the "SD&A Businesses") and program wins, partially offset by the completion of certain contracts, prior year upfront lease revenue recognized on certain programs and approximately $14 million of negative impacts from reduced volume on certain contracts due to COVID-19.
The increase in revenues for the nine months ended October 2, 2020, as compared to the nine months ended September 27, 2019, was primarily attributable to program wins, $154 million of revenues related to the acquisition of the SD&A Businesses and a net increase in volumes on certain programs. This was partially offset by the completion of certain contracts, approximately $45 million of negative impacts from reduced volume on certain contracts due to COVID-19 and an $11 million impact from the sale of our commercial cybersecurity business in the first quarter of fiscal 2019.
The increase in operating income for the three months ended October 2, 2020, as compared to the three months ended September 27, 2019, was primarily due to a net increase in volumes on certain programs, program wins and a decrease in bad debt expense. This was partially offset by higher amortization of intangible assets related to the acquisition of the SD&A Businesses and the completion of certain contracts.
The increase in operating income for the nine months ended October 2, 2020, as compared to the nine months ended September 27, 2019, was primarily attributable to program wins and a decrease in bad debt expense, partially offset by higher amortization of intangible assets related to the acquisition of the SD&A Businesses and the completion of certain contracts.
(dollars in millions)
| Health | Three Months Ended October 2, 2020 | September 27, 2019 | Dollar change | Percent change | Nine Months Ended October 2, 2020 | September 27, 2019 | Dollar change | Percent change |
|---|---|---|---|---|---|---|---|---|
| Revenues | $520 | $508 | $12 | 2.4% | $1,449 | $1,472 | $(23) | (1.6)% |
| Operating income | 75 | 63 | 12 | 19.0% | 149 | 169 | (20) | (11.8)% |
| Operating margin | 14.4% | 12.4% | 10.3% | 11.5% |
The increase in revenues for the three months ended October 2, 2020, as compared to the three months ended September 27, 2019, was primarily attributable to a net increase in volumes on certain programs and program wins. This was partially offset by a $22 million impact from the sale of our health staff augmentation business in the third quarter of fiscal 2019.
The decrease in revenues for the nine months ended October 2, 2020, as compared to the nine months ended September 27, 2019, was primarily attributable to approximately $96 million related to timing of program execution due to COVID-19, a $73 million impact from the sale of our health staff augmentation business in the third quarter of fiscal 2019 and the completion of certain contracts. This was partially offset by a net increase in volumes on certain programs, program wins and a $23 million impact from our acquisition of IMX Medical Management Services, Inc. ("IMX") in the third quarter of fiscal 2019.
The increase in operating income for the three months ended October 2, 2020, as compared to the three months ended September 27, 2019, was primarily due to lower expenditures on certain programs.
The decrease in operating income for the nine months ended October 2, 2020, as compared to the nine months ended September 27, 2019, was primarily attributable to approximately $56 million of negative impacts from reduced volume on certain managed service contracts with fixed cost infrastructures that were impacted by COVID-19, partially offset by a net increase in volumes on certain programs.
(dollars in millions)
| Corporate | Three Months Ended October 2, 2020 | September 27, 2019 | Dollar change | Percent change | Nine Months Ended October 2, 2020 | September 27, 2019 | Dollar change | Percent change |
|---|---|---|---|---|---|---|---|---|
| Operating (loss) income | $(16) | $36 | $(52) | NM | $— | $1 | $(1) | (100.0)% |
NM - Not meaningful
The increase in operating loss for the three months ended October 2, 2020, as compared to the three months ended September 27, 2019, was primarily attributable to a $54 million recovery recognized in the prior year quarter related to the receipt of the Greek arbitration award.
The decrease in operating income for the nine months ended October 2, 2020, as compared to the nine months ended September 27, 2019, was primarily attributable to a $54 million recovery recognized in the prior year quarter related to the receipt of the Greek arbitration award, a $26 million increase in acquisition and integration costs and higher litigation costs. This was partially offset by an $81 million net gain recognized upon the receipt of proceeds related to the VirnetX, Inc. ("VirnetX") legal matter.
Non-Operating Expense, net
Non-operating expense, net for the three months ended October 2, 2020 was $44 million as compared to $35 million for the three months ended September 27, 2019. The change was primarily due to higher interest expense associated with increases in our long-term debt.
Non-operating expense, net for the nine months ended October 2, 2020 was $163 million as compared to $12 million for the nine months ended September 27, 2019. The change was primarily due to the $87 million gain recognized on the sale of our commercial cybersecurity business in the prior year, $31 million of debt discount and deferred financing costs written off related to the refinancing of our term loans and bridge facilities and higher interest expense associated with increases in our long-term debt.
Provision for Income Taxes
For the three months ended October 2, 2020, our effective tax rate was 23.8% compared to 24.3% for the three months ended September 27, 2019. The decrease in the effective tax rate was primarily due to a net decrease in valuation allowance related to foreign taxes compared to the prior year quarter, partially offset by an increase in current period foreign taxes.
For the nine months ended October 2, 2020, our effective tax rate was 19.4% compared to 23.5% for the nine months ended September 27, 2019. The decrease in the effective tax rate was primarily due to an increase in benefits related to employee stock-based payments, federal research tax credits and higher prior period unrecognized tax benefits.
Bookings and Backlog
We recorded net bookings worth an estimated $4.3 billion and $14.5 billion during the three and nine months ended October 2, 2020, respectively, as compared to $5.2 billion and $11.5 billion for the three and nine months ended September 27, 2019, respectively.
The estimated value of our total backlog was as follows:
(in millions)
| Defense Solutions: | October 2, 2020 | January 3, 2020 |
|---|---|---|
| Funded backlog | $4,115 | $3,063 |
| Negotiated unfunded backlog | 13,746 | 11,974 |
| Total Defense Solutions backlog | $17,861 | $15,037 |
| Civil: | ||
| Funded backlog | $1,521 | $1,267 |
| Negotiated unfunded backlog | 7,028 | 2,978 |
| Total Civil backlog | $8,549 | $4,245 |
| Health: | ||
| Funded backlog | $1,208 | $1,083 |
| Negotiated unfunded backlog | 4,101 | 3,725 |
| Total Health backlog | $5,309 | $4,808 |
| Total: | ||
| Funded backlog | $6,844 | $5,413 |
| Negotiated unfunded backlog | 24,875 | 18,677 |
| Total backlog | $31,719 | $24,090 |
The change in backlog for the Defense Solutions and Civil reportable segments reflect $1,632 million and $574 million, respectively, of backlog acquired as a result of the acquisitions of Dynetics and the SD&A Businesses, respectively.
Backlog represents the estimated amount of future revenues to be recognized under negotiated contracts, both funded and unfunded. Backlog does not include unexercised option periods and future potential task orders expected to be awarded under indefinite delivery/indefinite quantity ("IDIQ"), General Services Administration Schedule or other master agreement contract vehicles, with the exception of certain IDIQ contracts where task orders are not competitively awarded and separately priced but instead are used as a funding mechanism, and where there is a basis for estimating future revenues and funding on future task orders is anticipated. Total backlog at October 2, 2020 included an adverse impact of $44 million when compared to total backlog at January 3, 2020, due to exchange rate movements in the British pound and Australian dollar when compared to the U.S. dollar. Backlog estimates are subject to change and may be affected by factors including modifications of contracts and foreign currency movements.
Liquidity and Capital Resources
Overview
As of October 2, 2020, we had $512 million in cash and cash equivalents. In January 2020, we entered into an unsecured revolving credit facility which can provide up to $750 million in additional borrowing, if required. This new credit facility replaced the previous secured credit facility with the same borrowing capacity. As of October 2, 2020, there were no borrowings outstanding under the credit facility and we were in compliance with the related financial covenants.
At October 2, 2020, and January 3, 2020, we had outstanding debt of $4.5 billion and $3.0 billion, respectively. In January 2020, we entered into a Credit Agreement with certain financial institutions, which provided for a senior unsecured term loan facility in an aggregate principal amount of $1.9 billion (the "Term Loan Facility"). We used the proceeds of the Term Loan Facility and cash on hand to repay in full all indebtedness, and terminate all commitments, under, and discharge and release all guarantees and liens existing in connection with the credit agreements entered into in August 2016.
Additionally, on January 17, 2020, we entered into a Bridge Credit Agreement with certain financial institutions, which provided for a senior unsecured 364-day bridge loan facility in an aggregate amount of $1.25 billion (the "Bridge Facility"). We used the proceeds of the Bridge Facility and cash on hand to fund the purchase of Dynetics and repay in full all third party indebtedness of Dynetics, terminate all commitments thereunder and discharge and release all existing guarantees and liens.
In February 12, 2020, we entered into a senior unsecured delayed-draw term loan facility (the "Facility") providing for $1.0 billion of commitments from certain financial institutions in connection with the acquisition of the SD&A Businesses. On May 4, 2020, we completed our acquisition of the SD&A Businesses and drew on the Facility in an aggregate principal amount of $1.0 billion. The proceeds of the Facility and cash on hand were used to fund the purchase of the SD&A Businesses.
On May 12, 2020, we issued and sold $500 million senior notes maturing in May 2023, $500 million senior notes maturing in May 2025 and $750 million senior notes maturing in May 2030 (collectively, the "Notes"). The proceeds from the Notes were used to repay all of the outstanding obligations in respect of principal, interest, fees and other amounts under the Bridge Credit Agreement and to repay a portion of the outstanding loans under the Facility.
On June 18, 2020, we entered into a 364-day Term Loan Credit Agreement, which provided for a senior unsecured term loan facility in an aggregate principal amount of $300 million (the "Term Loan"). The proceeds of the Term Loan and cash on hand on were used to repay in full all indebtedness under, and discharge and release all guarantees existing in connection with the Facility.
On September 1, 2020, we retired our $450 million senior unsecured notes due December 2020. Cash on hand was used to repay in full all indebtedness under, and discharge and release all guarantees existing in connection with the notes.
On October 8, 2020, we issued and sold $1.0 billion aggregate principal amount of fixed-rate senior notes maturing in February 2031 (the "2031 Notes"). The proceeds from the 2031 Notes were used for general corporate purposes, including to repay all of the outstanding obligations in respect of principal, interest, fees and other amounts under the 364-day Term Loan and to repay a portion of the outstanding loans under the five-year Term Loan Facility.
See "Note 10–Debt" and "Note 17–Subsequent Events" for further details regarding the debt transactions noted above.
In addition to the refinancing activity noted above, we made principal payments on our long-term debt of $477 million and $705 million during the three and nine months ended October 2, 2020, respectively, and $2 million and $50 million during the three and nine months ended September 27, 2019, respectively. This activity included required principal payments on our term loans of $24 million and $48 million during the three and nine months ended October 2, 2020, respectively, and $41 million during the nine months ended September 27, 2019. The senior unsecured term loans and notes contain financial covenants and customary restrictive covenants. We were in compliance with all covenants as of October 2, 2020.
We paid dividends of $49 million and $148 million during the three and nine months ended October 2, 2020, respectively, and $101 million during the nine months ended September 27, 2019.
During the three and nine months ended October 2, 2020, we sold $753 million and $1,866 million, respectively, of accounts receivable under accounts receivable purchase agreements and received proceeds of $752 million and $1,864 million, respectively (see "Note 13–Supplementary Cash Flow Information and Restricted Cash").
COVID-19 has negatively impacted the financial markets and may impact our liquidity; we will continue to assess our liquidity needs as the outbreak evolves.
For the next 12 months, we anticipate that we will be able to meet our liquidity needs, including servicing our debt, through cash generated from operations, available cash balances, sales of accounts receivable and, if needed, borrowings under our revolving credit facility.
Summary of Cash Flows
The following table summarizes cash flow information for the periods presented:
(in millions)
| Three Months Ended October 2, 2020 | September 27, 2019 | Nine Months Ended October 2, 2020 | September 27, 2019 | |
|---|---|---|---|---|
| Net cash provided by operating activities | $592 | $349 | $1,386 | $823 |
| Net cash (used in) provided by investing activities | (15) | (102) | (2,714) | 119 |
| Net cash (used in) provided by financing activities | (517) | (204) | 1,353 | (565) |
| Net increase in cash, cash equivalents and restricted cash | $60 | $43 | $25 | $377 |
Net cash provided by operating activities increased $243 million for the three months ended October 2, 2020, when compared to the prior year quarter. The increase was primarily due to the timing of payroll payments and higher advance payments from customers in the current year quarter.
Net cash provided by operating activities increased $563 million for the nine months ended October 2, 2020, when compared to the prior year. The increase was primarily due to the timing of payroll payments, $204 million from the sale of accounts receivable in the last month of the quarter and the receipt of $85 million of proceeds related to the VirnetX legal matter.
Net cash used in investing activities decreased $87 million for the three months ended October 2, 2020, when compared to the prior year quarter, primarily due to $94 million of cash paid related to the acquisition of IMX in the prior year quarter, partially offset by $12 million of net proceeds received for the divestiture of our health staff augmentation business in the prior year quarter.
Net cash used in investing activities increased $2,833 million for the nine months ended October 2, 2020, when compared to the prior year, primarily due to $2,610 million of net cash paid related to the acquisitions of Dynetics and the SD&A Businesses, $183 million received in the prior year for the disposition of our commercial cybersecurity and health staff augmentation businesses, $96 million of proceeds received for the sale of real estate properties in the prior year and higher purchases of equipment and leasehold improvements associated with our new global headquarters. This was partially offset by $94 million of cash paid related to the acquisition of IMX in the prior year quarter.
Net cash used in financing activities increased $313 million for the three months ended October 2, 2020, when compared to the prior year quarter, primarily due to the early repayment of our $450 million senior unsecured notes in the current quarter and the timing of dividend payments, partially offset by $200 million of stock repurchases in the prior year quarter.
Net cash provided by financing activities increased $1,918 million for the nine months ended October 2, 2020, when compared to the prior year, primarily due to $6,225 million of proceeds received related to the issuance of debt and $400 million of stock repurchases in the prior year. This was partially offset by $3,975 million of principal repayments related to refinancing of outstanding debt, $650 million of additional principal repayments on our outstanding debt in the current year and the timing of dividend payments.
Off-Balance Sheet Arrangements
We have outstanding performance guarantees and cross-indemnity agreements in connection with certain aspects of our business. We also have letters of credit outstanding principally related to performance guarantees on contracts and surety bonds outstanding principally related to performance and subcontractor payment bonds as described in "Note 16–Commitments" of the notes to the condensed consolidated financial statements contained within this Quarterly Report on Form 10-Q. These arrangements have not had, and management does not believe it is likely that they will in the future have, a material effect on our liquidity, capital resources, operations or financial condition.
Commitments and Contingencies
We are subject to a number of reviews, investigations, claims, lawsuits, other uncertainties and future obligations related to our business. For a discussion of these items, see "Note 15–Contingencies" and "Note 16–Commitments" of the notes to the condensed consolidated financial statements contained within this Quarterly Report on Form 10-Q.
Critical Accounting Policies
There were no material changes to our critical accounting policies, estimates or judgments during the period covered by this report from those discussed in our Annual Report on Form 10-K for the year ended January 3, 2020.
Recently Adopted and Issued Accounting Standards
For a discussion of these items, see "Note 1–Basis of Presentation and Summary of Significant Accounting Policies" of the notes to the condensed consolidated financial statements contained within this Quarterly Report on Form 10-Q.
Market risk
As filed, 369 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The broad effects of the COVID-19 outbreak have resulted in negative impacts on the global economy and financial markets and may affect our interest rates and cause foreign currency fluctuations.
Except as noted above, there were no material changes in our market risk exposure from those discussed in our Annual Report on Form 10-K for the year ended January 3, 2020.
Controls and procedures
As filed, 2,137 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer (our Chairman and Chief Executive Officer) and principal financial officer (our Executive Vice President and Chief Financial Officer), has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934) as of October 2, 2020. Based upon that evaluation, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the U.S. Securities and Exchange Commission. These disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
On January 31, 2020 and May 4, 2020, we completed the acquisitions of Dynetics and the SD&A Businesses, respectively. In conducting our evaluation of the effectiveness of our internal control over financial reporting, we excluded Dynetics and the SD&A Businesses from our evaluation for the third quarter of fiscal 2020. We are in the process of integrating Dynetics and the SD&A Businesses into our system of internal control over financial reporting.
Other than the foregoing, there have been no changes in our internal control over financial reporting that occurred in the quarterly period covered by this report that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 4,343 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Other than as described below, there have been no material changes to the risks described in Part I, Item 1A "Risk Factors" in our Annual Report on Form 10-K for the year ended January 3, 2020 and Part II, Item 1A “Risk Factors” in our Quarterly Report on Form 10-Q for the quarterly period ended July 3, 2020. If any risks and uncertainties described below actually occur, our business, financial condition or operating results could be materially harmed and the price of our stock could decline. Additional risks and uncertainties not currently known to us or that we currently believe are immaterial also may materially harm our business.
The extent to which our business will be adversely affected by the recent COVID-19 outbreak or other health epidemics, pandemics and similar outbreaks is highly uncertain and cannot be predicted.
The recent outbreak and global spread of COVID-19, and the preventative or protective actions that governments, corporations, individuals and we are taking and may continue to take in an effort to limit the impact of COVID-19, have resulted in a period of business disruption and increased economic uncertainty. The spread of COVID-19 has caused us to modify our business practices (including employee travel, access to customer sites, employee and contractor remote work and cancellation of physical participation in meetings, events and conferences), and we may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, customers and business partners. There is no certainty that such measures will be sufficient to mitigate the risks posed by COVID-19 or otherwise be satisfactory to government authorities. If significant portions of our workforce are unable to work effectively, including because of illness, quarantines, government actions, facility closures or other restrictions due to COVID-19, our operations and results will likely be impacted.
Government agencies are our primary customers and the long-term impact of increased government spending in response to COVID-19 is uncertain. For example, the U.S. government fiscal year 2021 budget cycle is delayed as the U.S. government focuses its attention on mitigating the impact of COVID-19, and a continuing resolution was enacted on October 1, 2020 to provide temporary funding for government operations through December 11, 2020. This could result in a re-evaluation of U.S. government spending levels and priorities, which could impact our business performance. Even after COVID-19 has subsided, we may experience materially adverse impacts on our business as a result of the outbreak's global economic impact, including any recession that is occurring or may occur in the future. New contract awards have been and may continue to be delayed and our ability to perform on our existing contracts has been and may continue to be delayed or impaired, which will negatively impact our revenues. In addition, our costs have increased and may continue to increase as a result of COVID-19, and these cost increases may not be fully recoverable or adequately covered by insurance, or equitable adjustments to contract prices or reimbursement of costs under Section 3610 of the CARES Act, which could impact our profitability. The continued spread of COVID-19 has had and may continue to have similar negative impacts on our customers, subcontractors and suppliers, causing delay or limiting their ability to perform, including in making timely payments to us. Any resulting financial impact cannot be reasonably estimated at this time but may materially and adversely affect our business, financial condition, results of operations and cash flows. The extent to which COVID-19 impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, including new information that may emerge concerning the severity and duration of COVID-19 and actions to contain it or treat its impact, among others. In addition, to the extent COVID-19 or any worsening of the global business and economic environment as a result adversely affects our business and financial results, it may also have the effect of heightening many of the other risks described under Part I, Item 1A "Risk Factors" of our most recent Annual Report on Form 10-K.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-10-02. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-07-04 to 2020-10-02 | $3.22bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2020-01-04 to 2020-10-02 | $8.97bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2020-07-04 to 2020-10-02 | $2.77bn | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2020-01-04 to 2020-10-02 | $7.80bn | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2020-07-04 to 2020-10-02 | $200.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-01-04 to 2020-10-02 | $583.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-07-04 to 2020-10-02 | $258.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-01-04 to 2020-10-02 | $699.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2020-07-04 to 2020-10-02 | $51.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-01-04 to 2020-10-02 | $104.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-07-04 to 2020-10-02 | $163.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-01-04 to 2020-10-02 | $431.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-07-04 to 2020-10-02 | $1.13 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-01-04 to 2020-10-02 | $2.99 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-07-04 to 2020-10-02 | $1.15 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-01-04 to 2020-10-02 | $3.04 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-07-04 to 2020-10-02 | 144,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-01-04 to 2020-10-02 | 144,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-01-04 to 2020-10-02 | $1.39bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-01-04 to 2020-10-02 | $120.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2020-10-02 | $512.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-10-02 | $3.20bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-10-02 | $12.29bn | us-gaap:Assets |
| Current liabilities | At period end2020-10-02 | $3.40bn | us-gaap:LiabilitiesCurrent |
| Current portion of debt | At period end2020-10-02 | $401.0m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2020-10-02 | $3.71bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001336920-20-000083. Last ingested by Listed: Nov 3, 2026, 11:59 ET. Listed shows no prices and gives no investment advice.